Perspective Therapeutics (CATX)

• Market cap: $464M
• 1 day: -2.16%
• 5 days: 10%
• 1 month: 3.04%
• 3 months: -23.93%
• 6 months: 73.19%
• Year to date: 45.88%
• 1 year: 57.75%
• 5 years: -49.13%
• 10 years: -57.16%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Employees: 166